Compass Pathways to Highlight Scientific Research and TRD Disease State Education Efforts at the 2026 Neuroscience Education Institute Fall Congress
Stocks in this Quantisnow insightHealth Care
Historical context for CMPS
Across the 26 sessions after earlier CMPS headlines, the stock closed higher 14 times and lower 12 times, with a median move of 2.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CMPS | SPY |
|---|---|---|---|
| Oct 27, 2026 | Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 2026 | +6.9% | +0.6% |
| Oct 14, 2026 | Compass Pathways Joins Forces with Leading Mental Health Organizations to Mark First-Ever U.S. Treatment-Resistant Depression (TRD) Awareness Day | +1.2% | -1.1% |
| Oct 2, 2026 | Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | -0.4% | +0.7% |
| Sep 30, 2026 | Compass Pathways Appoints Kelley Boucher as Chief People Officer | -4.0% | -0.2% |
| Sep 16, 2026 | Compass Pathways to Participate in TD Cowen 6th Annual Novel Mechanisms in Neuropsychiatry Summit on September 23, 2026 | -0.1% | -0.4% |
| Sep 15, 2026 | Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 2026 | -5.0% | -0.5% |
Quantisnow market dataNASDAQ
CMPS
COMPASS Pathways Plc
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2020
Get push alerts for CMPS
Full CMPS profile on Quantisnow Follow CMPS and get a push notification the moment its next story breaks.